Scribe Therapeutics Inc.(SCTX:US)
Market Cap$380.15M
Key Metrics
Price$20.08
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$20.38M
Total Assets$65.21M
Net Assets-$158.74M
Total Debt$46.33M
Key Metrics
Price$20.08
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$20.38M
Total Assets$65.21M
Net Assets-$158.74M
Total Debt$46.33M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $2.23M | $17.13M |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $14.66M | $22.68M | |
| Research and Development | $11.31M | $15.99M |
| Selling, General, and Administrative | $3.36M | $6.69M |
| Other Operating Expenses | - | - |
Operating Income | -$12.43M | -$5.56M |
| -$4.69M | $1.82M | |
| Non-Operating Interest Income | $515K | $1.06M |
| Non-Operating Interest Expense | $598K | $598K |
| Other Income/Expense | -$4.61M | $1.35M |
Income Before Tax | -$17.12M | -$3.74M |
Income Tax | $228K | -$315K |
Net Income | -$17.35M | -$3.43M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$17.35M | -$3.43M |
Shares Outstanding (Basic) | - | - |
Shares Outstanding (Diluted) | - | - |
EPS (Basic) | - | - |
EPS (Diluted) | - | - |
EBIT | -$16.52M | -$3.14M |
EBITDA | -$15.75M | -$2.28M |